UNSPSC 51384614: Mofebutazone

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51384614

Definition

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C13H16N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SPW36WUI5Z, chemically known as 3,5-pyrazolidinedione, 4-butyl-1-phenyl- but generally known as mofebutazone, which bears US NIH Compound Identifier 16639. European Medicines Agency schedules Mofebutazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09033MIG. The term MOFEBUTAZONE is an International Non-Proprietary Name.

Read the full definition

World Health Organization schedules mofebutazone in its Anatomical Therapeutic Chemical (ATC) Classification. MOFEBUTAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mofebutazone under HS 29331990 and SITC 51571. As of Q4 2014, MOFEBUTAZONE remains the US FDA Preferred Term for this commodity. Mofebutazone bears US NLM identifiers UMLS ID C0066774 and NCI Concept Code C73089. SMILES: O=C1N(NC(=O)C1CCCC)C1CCCCC1.

About UNSPSC 51384614

UNSPSC 51384614 Mofebutazone, a Commodity code, shows minimal alignment with actual state and local procurement activity. The code nominally describes a specific pharmaceutical compound, but the single recent opportunity sourced under it—Seminole County, Florida's IFB for naloxone and drug deactivation systems—concerns emergency medical supplies and harm-reduction equipment rather than mofebutazone, an anti-inflammatory veterinary drug. The mismatch suggests either a classification error in the county's tagging or a fundamental misalignment between the code's pharmaceutical scope and the goods state and local governments are actually procuring under this designation.

Seminole County's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually via quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement required vendors to submit electronically through the county's e-Procurement Portal, include all shipping and delivery costs in their bids, comply with drug-free workplace and E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract included a two-year initial term with a one-year renewal option and a three-month probationary termination period. No explicit set-asides for disadvantaged enterprises were specified, though the procurement carried potential FEMA funding and associated federal compliance obligations. No additional state and local opportunities under this code appear in the recent activity block, indicating extremely limited or non-existent procurement volume under UNSPSC 51384614 at the state and local level.

Quick answers

What is UNSPSC 51384614?

UNSPSC 51384614 is Mofebutazone, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51384614?

UNSPSC 51384614 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51384614

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code